Table 5.
Weight gains and percent of optimum anticoccidial activity.
| Drugs1 | Initial body weight (g) | Final body weight (g) | GSR | Percent of optimum anticoccidial activity (POAA, %) |
|---|---|---|---|---|
| SC | 64.2±6.20 | 101.4±17.5 a | 1.58 | 60.1 |
| AM | 63.6±7.54 | 87.0±11.9 b | 1.37 | 5.30 |
| TOL | 62.5±8.26 | 106.6±11.0 a | 1.71 | 94.7 |
| CL | 64.4±5.42 | 100.3±21.29 a | 1.56 | 55.3 |
| SA | 62.8±10.30 | 106.5±20.9 a | 1.70 | 92.1 |
| NI | 66.2±6.79 | 103.2±15.1 a | 1.56 | 55.3 |
| P-ctl | 64.8±4.26 | 87.4±17.9 b | 1.35 | / |
| N-ctl | 65.3±6.52 | 112.7±14.7 a | 1.73 | / |
1
AM, amproline; CL, clopidol; GSR, the final weight including the cage weight ÷ the initial weight including the cage weight; NI, Nicarbazine; P-ctl, infected-unmedicated positive control; SA, Salinomycin; SC, sulfachloropyrazine sodium; TOL, toltrazuril.
a,b
The same superscripts mean no difference, the different superscripts represent significant differences (P < 0.05).